Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124477192 | 12447719 | 2 | F | 201509 | 20160629 | 20160608 | 20160705 | EXP | US-UCBSA-2016020897 | UCB | 58.28 | YR | F | Y | 0.00000 | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124477192 | 12447719 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 2 WEEKS(QOW), NDC NUMBER: 50474-0710-79 | Y | 901706 | 125160 | 200 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 124477192 | 12447719 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 3 WEEKS | Y | 125160 | 200 | MG | SOLUTION FOR INJECTION | Q3W | |||||
| 124477192 | 12447719 | 3 | C | LATANOPROST. | LATANOPROST | 1 | Ophthalmic | 0.005 %, UNK | U | 0 | .005 | PCT | EYE DROPS | ||||||
| 124477192 | 12447719 | 4 | C | ALTACE | RAMIPRIL | 1 | UNK, FREQUENCY : DAILY | U | 0 | ||||||||||
| 124477192 | 12447719 | 5 | C | Clobetasol | CLOBETASOL | 1 | Topical | UNK | U | 0 | |||||||||
| 124477192 | 12447719 | 6 | C | CALCIPOTRIENE. | CALCIPOTRIENE | 1 | Topical | UNK | U | 0 | |||||||||
| 124477192 | 12447719 | 7 | C | TOBRAMYCIN. | TOBRAMYCIN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124477192 | 12447719 | 1 | Rheumatoid arthritis |
| 124477192 | 12447719 | 3 | Glaucoma |
| 124477192 | 12447719 | 4 | Hypertension |
| 124477192 | 12447719 | 5 | Psoriasis |
| 124477192 | 12447719 | 6 | Psoriasis |
| 124477192 | 12447719 | 7 | Keratitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124477192 | 12447719 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124477192 | 12447719 | Keratitis | |
| 124477192 | 12447719 | Off label use | |
| 124477192 | 12447719 | Oropharyngeal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124477192 | 12447719 | 1 | 201401 | 2016 | 0 | |
| 124477192 | 12447719 | 2 | 201605 | 0 |